Summary
Mice infected i.v. with high doses of lymphocytic choriomeningitis virus (LCMV; 105–106 plaqueforming units) 8–10 days prior to challenge with the methylcholanthrene-induced fibrosarcoma tumor cell line MC57G or the melanoma cell line B16 tumor cells showed an enhanced tumor susceptibility with respect to both growth kinetics of the tumor and the minimal dose necessary for tumor take. After transient initial growth, MC57G tumor cells were all rejected by uninfected C57BL/6 mice by day 14. Mice preinfected i.v. with LCMV 3 weeks before or at the time of tumor challenge, but not those infected 2 months before or 7 days after, showed increasing tumor growth, the tumor take being 100% for 106, 50% for 105 and 37% for 104 MC57G tumor cells injected into the footpad compared with resistance to 106 cells in normal mice. B16 melanoma cells also grew more rapidly in LCMV-preinfected mice and by day 40 tumors were established with about 100 times fewer cells, i.e. about 103 compared with 3×104−3×105 for uninfected mice. Analysis of the growth of tumor cells in normal and in LCMV-carrier mice revealed that the latter mice were not more susceptible to LCMV-infected than to uninfected MC57G. Since LCMV-carrier mice fail to mount LCMV-specific T cell responses, these results suggest that anti-LCMV-specific T cells may be responsible for acquired immunodeficiency hampering immune surveillance against the tumors studied.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aden DP, Knowles BB (1976) Cell surface antigen coded for the human chromosome 7. Immunogenetics 3: 209
Ahmed R, King C, Oldstone MBA (1987) Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo. J Virol 61: 1571
Bekesi JG, St-Arneault G, Holland JF (1972) Immunogenicity of leukemia L1210 cells after neuraminidase treatment. J Natl Cancer Inst 49: 107
Boog CJP, Boes J, Melief CJM (1988) Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses. Eur J Immunol 18: 219
Boone CW, Blackman K (1972) Augmented immunogenicity of tumor cell homogenates infected with influenza virus. Cancer Res 32: 1018
Bro-Jörgensen K, Volkert M (1974) Defect in the immune system of mice infected with lymphocytic choriomeningitis virus. Infect Immun 9: 605
Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MBA (1980) The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 30: 275
Centers of Disease Control Task Force (1982) Epidemiological aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. N Engl J Med 306: 248
Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H (1984) Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 312: 548
Cole GA, Nathanson N, Prendergast RA (1972) Requirement for thetabearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 238: 335
Doherty PC, Zinkernagel RM (1974) T cell-mediated immunopathology in viral infection. Transplant Rev 19: 89
Fauci AS (1988) The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 239: 617
Fernandez-Cruz E, Woda BA, Feldman JD (1980) Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes J Exp Med 152: 823
Fidler IJ (1973) Selection of successive tumor lines for metastasis. Nature 242: 148
Fidler IJ, Nicolson GL (1976) Brief communication: organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 57: 1199
Fujiwara H, Moriyama Y, Suda T, Tsuchida T, Shearer GM, Hamaoka T (1984) Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression. J Immunol 132: 1571
Fujiwara H, Yoshioka T, Shima J, Kosugi A, Itoh K, Hamaoka T (1986) Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses. J Immunol 136: 2715
Gold K, Thomas D, Garret TJ (1982) Aggressive Kaposi's sarcoma in a heterosexual drug addict (New York City). N Engl J Med 307: 498
Hamburg V, Svet-Moldavsky G (1967) Suppression of viral and chemical carcinogenesis by means of artificial heterogenization. Nature 215: 230
Hotchin J (1971) Persistent and slow virus infections. Monogr Virol 3: 1
Jacobson S, Friedman RM, Pfau CJ (1981) Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence. J Gen Virol 57: 275
Lehmann-Grube F (1971) Lymphocytic choriomeningitis virus. Virol Monogr 10: 1
Lehmann-Grube F (1984) Bacterial and viral inhibition and modulation of host defences. Academic Press, London, pp 211–242
Lehmann-Grube F, Ambrassat J (1977) A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera. J Gen Virol 37: 85
Lehmann-Grube F, Assmann-Wischer U, Löliger C, Moskophidis D, Löhler J (1985) Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in clearance of lymphocytic choriomeningitis virus from spleens of mice. J Immunol 134: 608
Leist TP, Cobbold SP, Waldmann H, Aguet M, Zinkernagel RM (1987) Functional analysis of T lymphocyte subsets in antiviral host defense, J Immunol 138: 2278
Leist TP, Eppler M, Rüedi E, Zinkernagel RM (1988) Virus triggered AIDS in mice is a T cell mediated immunopathology caused by virus-specific cytotoxic T cells: prevention by tolerance or by treatment with anti-CD8 antibodies. J Exp Med 167: 1749
Leist TP, Eppler M, Zinkemagel RM (1989) Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-IFN gamma-treated mice. J Virol 63: 2813
Levy JA, Ziegler JL (1983) Acquired immune deficiency syndrome (AIDS) is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet 2: 78
Lindenmann J, Klein PA (1967) Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J Exp Med 126: 93
Löhler J, Lehmann-Grube F (1981) Immunopathologic alterations of lymphatic tissues of mice infected with lymphocytic choriomeningitis virus. I Histopathologic findings. Lab Invest 44: 193
Mims CA (1966) Immunofluorescene study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice. Pathol Bacteriol 91: 395
Mims CA, Subrahmanyan TP (1966) Immunofluorescence study of the mechanism of resistance to superinfection in mice carrying the lymphocytic choriomeningitis virus. J Pathol Bacteriol 91: 403
Mims CA, Wainwright S (1968) The immunodepressive action of lymphocytic choriomeningitis virus in mice. J Immunol 101: 717
Minato N, Bloom BR, Jones Ch, Holland J, Reid LM (1979) Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med 119: 1117
Molomut N, Padnos M, Gross L, Satory V (1964) Inhibition of a transplantable murine leukaemia by a lymphocytopenic virus. Nature 204: 1003
Moore A (1960) The oncolytic viruses. Prog Exp Tumor Res 1: 411
Oldstone MBA, Tishon A, Chiller JM, Weigle WO, Dixon FJ (1973) Effect of chronic viral infection on the immune system: I. comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice. J Immunol 110: 1268
Popescu M, Löhler J, Lehmann-Grube F (1979) Infectious lymphocytes in lymphocytic choriomeningitis virus carrier mice. J Gen Virol 42: 481
Quinn TC, Mann JM, Curran JW, Piot P (1986) AIDS in africa: an epidemiologic paradigm. Science 234: 955
Rogers MF, Morens DM, Stewart JA et al. (1983) National casecontrol study of Kaposi's sarcoma and pneumocystis carinii pneumonia in homosexual men: II. Laboratory results. Ann Intern Med 99: 151
Roost HP, Charan S, Gobet R, Rüedi E, Hengartner H, Althage A, Zinkernagel RM (1988) An acquired immunodeficiency in mice caused by infection with lymphocytic choriomeningitis virus. Eur J Immunol 18: 511
Schroff R, Gottlieb MS, Prince HE et al. (1983) Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol 27: 300
Shearer GM (1986) AIDS: an autoimmune pathologic model for the destruction of a subset of helper T lymphocytes. Mount Sinai 53: 609
Takai Y, Kosugi A, Yoshioka T, Tomita S, Fujiwara H, Hamaoka T (1985) T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) respones: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses. J Immunol 134: 108
Traub E (1936) Persistence of lymphocytic choriomeningitis virus in immune animals and its relation to immunity. J Exp Med 63: 847
Traub E (1962) Can LCMV virus cause lymphomatosis in mice? Arch Gesamte Virusforsch 11: 667
Van Pel A, Boon Th (1982) Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis. Proc Natl Acad Sci USA 79: 4718
Walker CM, Moody DJ, Stites DP, Levy JA (1986) CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234: 1563
Welsh RM, Zinkernagel RM (1977) Heterospecific cytotoxic cells during acute lymphocytic choriomeningitis virus infection. Nature 268: 646
Wheelock EF, Toy ST (1973) Participation of lymphocytes in viral infections. Adv Immunol 16: 123
Wise KS (1977) Vesicular stomatitis virus-infected L1210 murine leukemia cells: increased immunogenicity and altered surface antigens. J Natl Cancer Inst 58: 83
Youn JK, Barski G (1966) Interference between lymphocytic choriomeningitis and rauscher leukemia in mice. J Natl Cancer Inst 37: 381
Yu AS, Bernstein ID (1982) T helper cells in immune mice amplify the primary anti-tumor cytotoxic response. J Immunol 129: 856
Zeigler JL, Stites DP (1986) Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol 41: 305
Zinkernagel RM (1988) Virus triggered AIDS is a T cell mediated immunopathology: prevention by tolerance or by treatment with anti-CD8 antibodies. Immunol Today 9: 370
Author information
Authors and Affiliations
Additional information
Supported by grants from the Swiss National Science Foundation 3.259–0.87 and the Kanton of Zürich
Rights and permissions
About this article
Cite this article
Kohler, M., Rüttner, B., Cooper, S. et al. Enhanced tumor susceptibility of immunocompetent mice infected with lymphocytic choriomeningitis virus. Cancer Immunol Immunother 32, 117–124 (1990). https://doi.org/10.1007/BF01754208
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01754208